| J0897 | Injection, denosumab, 1 mg | 1,740 | $20 | $31.3K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 710 | $40 | $29.8K |
| 90677 | This code represents a vaccine product administered intramuscularly to protect against pneumococcal disease, a bacterial infection. This is a 20–valent vaccine, protecting against 20 strains of the… | 60 | $280 | $16K |
| 90662 | This code represents a flu vaccine product that is a split virus type, contains no preservatives, and has enhanced effectiveness due to a higher antigen content. It is administered as an injection… | 100 | $70 | $7.3K |
| 91304 | This code represents a SARS–CoV–2 vaccine product administered by intramuscular injection to prevent the patient from contracting COVID–19. The dosage is 5 mcg/0.5 mL. | 40 | $150 | $5.1K |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 130 | $40 | $5K |
| G0008 | Administration of influenza virus vaccine | 110 | $30 | $3.2K |
| 87637 | The lab analyst performs the technical steps to detect and differentiate severe acute respiratory syndrome coronavirus 2 (SARS–CoV–2), influenza A, influenza B, and respiratory syncytial virus (RSV)… | 20 | $140 | $2.2K |
| G0009 | Administration of pneumococcal vaccine | 60 | $30 | $1.7K |
| 77080 | The provider performs an imaging procedure, called dual–energy X–ray absorptiometry (DXA), of one or more bony areas on the trunk to determine the bone mineral density (BMD) and whether the patient… | 40 | $30 | $1.3K |